Barclays Upgrades Arkema (OTCMKTS:ARKAY) to Hold

Arkema (OTCMKTS:ARKAYGet Free Report) was upgraded by equities research analysts at Barclays from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Other analysts also recently issued reports about the company. Sanford C. Bernstein upgraded Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Zacks Research upgraded Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Arkema in a research note on Tuesday, June 23rd. The Goldman Sachs Group lowered shares of Arkema from a “buy” rating to a “neutral” rating in a report on Monday, June 8th. Finally, Kepler Capital Markets cut shares of Arkema from a “hold” rating to a “strong sell” rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold”.

View Our Latest Stock Analysis on ARKAY

Arkema Price Performance

ARKAY stock opened at $71.81 on Wednesday. The company’s 50 day simple moving average is $65.99 and its 200-day simple moving average is $67.92. The firm has a market capitalization of $5.46 billion, a PE ratio of 247.62 and a beta of 0.85. Arkema has a 12 month low of $56.28 and a 12 month high of $79.36. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.64.

Arkema (OTCMKTS:ARKAYGet Free Report) last issued its quarterly earnings data on Thursday, July 30th. The basic materials company reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.86 by $0.12. The business had revenue of $2.79 billion during the quarter, compared to analysts’ expectations of $2.86 billion. Arkema had a net margin of 0.67% and a return on equity of 4.27%. Equities analysts expect that Arkema will post 3.67 earnings per share for the current fiscal year.

About Arkema

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

Further Reading

Analyst Recommendations for Arkema (OTCMKTS:ARKAY)

Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.